C. Randal Mills - 21 Jun 2023 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for C. Randal Mills
Issuer symbol
ELUT
Transactions as of
21 Jun 2023
Net transactions value
-$18,731
Form type
4
Filing time
23 Jun 2023, 11:30:51 UTC
Previous filing
28 Apr 2023
Next filing
02 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZYO Class A Common Stock Options Exercise +22,474 +47% 70,482 21 Jun 2023 Direct F1
transaction AZYO Class A Common Stock Tax liability $18,731 -7,772 -11% $2.41 62,710 21 Jun 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AZYO Restricted Stock Units Options Exercise $0 -22,474 -25% $0.000000 67,419 21 Jun 2023 Class A Common Stock 22,474 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
F2 Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
F3 On June 21, 2022, the Reporting Person was granted 89,893 restricted stock units, vesting in four substantially equal annual installments beginning in June 21, 2023.